secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2022-08-08T23:59:59+00:00
Accession:  0000950170-22-015514
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q2 revenue $11.4M (+132% YoY); raises FY22 guidance to $44-46M
----------------------------------------------------------------------

- Revenue $11.4M (+132% YoY); sold 49 LDDs, installed base 294 (+126% YoY).
- LAL procedure volumes 5,400 (+196% YoY).
- Net loss $(16.7)M ($0.61/share); adjusted loss $(13.8)M ($0.50/share).
- Raised FY22 revenue guidance to $44-46M (95-104% growth); gross margin guidance to 37-38%.
- Cash and investments $128.6M; long-term debt $39.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022015514/0000950170-22-015514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022015514/rxst-20220808.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-015514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer